Nina Tamirisa

ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2− Breast Cancer Undergoing Mastectomy

Jennifer Chen, Kerollos Nashat Wanis, Mahdia Rahman, Ayushi Gianchandani et autres

us, gb (code pays fourni par la source)

Polyostotic Fibrous Dysplasia Associated with GNAS Mutation in a Patient with Triple Negative Breast Cancer

Benjamin H. Perkins, John E. Madewell, Nina Tamirisa, Beatriz E. Adrada et autres

Fibrous dysplasia (FD) is a benign neoplasm of bone which is primarily characterized by the inability of bone-forming tissue to produce mature lamellar bone, instead arresting as woven bone[1]. FD may be present in one bone (monostotic) or have multiple foci (polyostotic) …

Implications for sentinel lymph node biopsy (SLNB) omission in patients with early-stage node-negative HR+/HER2- breast cancer undergoing mastectomy.

Jennifer Chen, Kerollos Nashat Wanis, Ayushi Gianchandani, Isabelle Bedrosian et autres

580 Background: The SOUND and INSEMA trials demonstrated non-inferiority of SLNB omission in HR+/HER2- early-stage breast cancer (BC) patients with negative axillary ultrasound (AUS) undergoing breast conserving therapy (BCT). However, it remains unclear if this approach may be applied to patients receiving …

us, gb (code pays fourni par la source)

Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers

Kerollos Nashat Wanis, Melissa P. Mitchell, Sharon H. Giordano, Jennifer K. Litton et autres

BACKGROUND: Selective omission of sentinel lymph node biopsy (SLNB) in patients with early breast cancer limits surgical morbidity. Adoption of this strategy relies on multidisciplinary consensus. Understanding how SLNB omission influences guideline-based adjuvant treatment decisions, and the proportion of patients impacted, can …

us (code pays fourni par la source)

Predicting pathologic ≥N2 disease in women with breast cancer

Kerollos Nashat Wanis, Wenli Dong, Yu Shen, Funda Meric‐Bernstam et autres

The distinction between pN1 and ≥pN2 breast cancer impacts treatment decisions. Using data from a single institution on women with cN0 invasive breast cancer who were treated with upfront surgery, had 1-3 positive SLNs, and underwent completion ALND, we used gradient boosted …

us (code pays fourni par la source)

Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer

Nina Tamirisa, Wenli Dong, Yu Shen, Heather Lin et autres

We sought to determine whether sequencing of treatment impacted outcomes in older, comorbid patients. Using the National Cancer Database(2010-2017), 2911 patients >70 with a Charleson Deyo Comorbidity(CCDM) score of 2/3 and cT1c-3/N0-3/HER2 positive or triple-negative breast cancer treated with chemotherapy,surgery,or both were …

us (code pays fourni par la source)

Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ

Ann H. Partridge, Terry Hyslop, Shoshana M. Rosenberg, Antonia V. Bennett et autres

Importance: Active monitoring (AM) for low-risk ductal carcinoma in situ (DCIS) has been considered as a potential alternative to guideline-concordant care (GCC; inclusive of surgery with or without radiation). Reported data comparing patient-reported outcomes (PROs) between GCC and AM for DCIS are …

us, gb (code pays fourni par la source)

ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy

Natasha Muppidi, Taiwo Adesoye, Min Yi, Susie X. Sun et autres

us (code pays fourni par la source)

Survival outcomes after omission of surgery for ductal carcinoma in situ

Elizabeth C. Poli, Wenli Dong, Simona F. Shaitelman, Nina Tamirisa et autres

Clinical trials of active surveillance (AS) for Ductal Carcinoma in Situ (DCIS) are underway. We sought to understand the historical management of biologically favorable DCIS and to determine the outcomes of patients who did not have immediate surgery. Using data from the …

us (code pays fourni par la source)

Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy

Natasha Muppidi, Taiwo Adesoye, Min Yi, Susie X. Sun et autres

us (code pays fourni par la source)

Premastectomy Radiotherapy and Immediate Breast Reconstruction

Mark V. Schaverien, Puneet Singh, Benjamin D. Smith, Wei Qiao et autres

Importance: Premastectomy radiotherapy (PreMRT) is a new treatment sequence to avoid the adverse effects of radiotherapy on the final breast reconstruction while achieving the benefits of immediate breast reconstruction (IMBR). Objective: To evaluate outcomes among patients who received PreMRT and regional nodal …

us (code pays fourni par la source)

Correction: Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery

Youngran Kim, Cecilia Ganduglia‐Cazaban, Nina Tamirisa, Anthony Lucci et autres

Correction: Annals of Surgical Oncology 10.1245/s10434-024-14902-z The article “Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast‑Conserving Surgery”, written by Kim et al. was originally published electronically on the publisher’s internet portal on February …

us (code pays fourni par la source)